Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29Rectal Neoplasms 8Colonic Neoplasms 7Carcinoma, Hepatocellular 7Cholangiocarcinoma 5Stomach Neoplasms 4Neoplasm Metastasis 4Neoplasms 3Biliary Tract Neoplasms 3Adenocarcinoma Of Esophagus 3Ovarian Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Solid Tumors 1Recurrence 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Lung Neoplasms 1Locally Advanced Rectal Cancer 1Locally Advanced Colorectal Carcinoma 1Liver Neoplasms 1Gastroesophageal Junction Adenocarcinoma 1Gastroesophageal Adenocarcinoma 1Gastro-enteropancreatic neuroendocrine tumor 1Endometrial Neoplasms 1Disease Progression 1Colorectal Cancer Metastatic 1

Interventions

Fluorouracil 3lenvatinib 2Oxaliplatin 2Leucovorin 2Drug Therapy 2gemcitabine-oxaliplatin regimen 1durvalumab 1donafenib 1apatinib 1Surgical Procedures, Operative 1Irinotecan 1Folfox protocol 1Floxuridine 1Dexamethasone 1Cryosurgery 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cirrhosis, Familial, with Pulmonary Hypertension × Folfox protocol × 1 year × Clear all
NCT07353827 2026-01-20

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Sun Yat-sen University

Phase 2 Not yet recruiting
36 enrolled
Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡